MDP — Medexus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$129.38m
- CA$144.11m
- $108.33m
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million
Canada's Medexus Pharmaceuticals Q1 revenue beats estimates
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.754 Million Vs. IBES Estimate USD 24.6 Million
Brief: Medexus Pharmaceuticals Announces Pricing Of $30 Million Overnight Marketed Public Offering Of Common Shares
Brief: Medexus Pharmaceuticals & Medac Conclude Negotiations To Amend Us Treosulfan Agreement
Brief: Medexus Announces New License Deal For Topical Terbinafine
Brief: Medexus Announces $58.5 Mln In New Credit Facilities
Canada Research Roundup: Bombardier, Great-West Lifeco, Sun Life Financial
Brief: Medexus Q3 Revenue Up 35%
Brief: Medexus Secures Public Reimbursement For Cuvposa® In Quebec
Brief: Medexus Pharmaceuticals Expects Record Revenue For Fiscal Q3 2023
Brief: Medexus Pharmaceuticals Inc Reports Q2 Revenue Rose 55 Percent To $27.7 Million
Canada Research Roundup: Advantage Energy, NFI Group, Nuvista Energy
Brief: Medexus Announces Preliminary Revenue Results For Second Fiscal Quarter 2023
Canada Research Roundup: Aurora Cannabis, Cathedral Energy Services, Teck Resources
Brief: Medexus Provides Update On Treosulfan NDA Resubmission, Provides Business Update